Reduced lean mass in early Alzheimer disease and its association with brain atrophy

Archives of Neurology

Volumn 67, Issue 4, 2010, Pages 428-433

  Burns, Jeffrey M ^a   Johnson, David K ^b   Watts, Amber ^b   Swerdlow, Russell H ^a   Brooks, William M ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BRAIN ATROPHY; BRAIN SIZE; CASE CONTROL STUDY; COGNITION; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; WHITE MATTER;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; AGED; ALZHEIMER DISEASE; ATROPHY; BIOLOGICAL MARKERS; BODY MASS INDEX; BRAIN MAPPING; CASE-CONTROL STUDIES; COGNITION DISORDERS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NEUROPSYCHOLOGICAL TESTS; SARCOPENIA; THINNESS; WEIGHT LOSS;

EID: 77950911528     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2010.38     Document Type: Article

References (41)

1. White H, Pieper C, Schmader K. The association of weight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis. J Am Geriatr Soc. 1998;46(10):1223-1227. (Pubitemid 28467424)
2. Johnson DK, Wilkins CH, Morris JC. Accelerated weight loss may precede diagnosis in Alzheimer disease. Arch Neurol. 2006;63(9):1312-1317.
3. Knopman DS, Edland SD, Cha RH, Petersen RC, Rocca WA. Incident dementia in women is preceded by weight loss by at least a decade. Neurology. 2007;69(8):739-746.
4. Barrett-Connor E, Edelstein SL, Corey-Bloom J, Wiederholt WC. Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc. 1996;44(10):1147-1152. (Pubitemid 26338826)
5. Cronk BB, Johnson DK, Burns JM; and the Alzheimer's Disease Neuroimaging Initiative. Body mass index and cognitive decline in mild cognitive impairment [published online June 30, 2009]. Alzheimer Dis Assoc Disord. doi:10.1097/WAD.0b013e3181a6bf3f.
6. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP Jr, Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study [published online ahead of print April 29, 2005]. BMJ. 2005;330(7504):1360.
7. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med. 2003;163(13):1524-1528. (Pubitemid 36835095)
8. Atti AR, Palmer K, Volpato S, Winblad B, De Ronchi D, Fratiglioni L. Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen project. 2008;56:111-116.
9. Luchsinger JA, Patel B, Tang M-X, Schupf N, Mayeux R. Measures of adiposity and dementia risk in elderly persons. 2007;64:392-398.
10. Grundman M, Corey-Bloom J, Jernigan T, Archibald S, Thal LJ. Low body weight in Alzheimer's disease is associated with mesial temporal cortex atrophy. Neurology. 1996;46(6):1585-1591. (Pubitemid 26185776)
11. Buchman AS, Schneider JA, Wilson RS, Bienias JL, Bennett DA. Body mass index in older persons is associated with Alzheimer disease pathology. Neurology. 2006;67(11):1949-1954. (Pubitemid 44967369)
12. Burns JM, Cronk BB, Anderson HS, et al. Cardiorespiratory fitness and brain atrophy in early Alzheimer disease. Neurology. 2008;71(3):210-216.
13. Burns JM, Donnelly JE, Anderson HS, et al. Peripheral insulin and brain structure in early Alzheimer disease. Neurology. 2007;69(11):1094-1104.
14. Burns JM, Mayo MS, Anderson HS, Smith HJ, Donnelly JE. Cardiorespiratory fitness in early-stage Alzheimer disease. Alzheimer Dis Assoc Disord. 2008;22(1):39-46.
15. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412-2414.
16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34(7):939-944. (Pubitemid 14076461)
17. Berg L, McKeel DW Jr, Miller JP, et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol. 1998;55(3):326-335. (Pubitemid 28146197)
18. Storandt M, Grant EA, Miller JP, Morris JC. Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI. Neurology. 2006;67(3):467-473. (Pubitemid 44214972)
19. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 2001;58(3):397-405. (Pubitemid 32217456)
20. Galasko D, Bennett D, Sano M, et al. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease: the Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997;11(suppl 2):s33-s39.
21. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278-296.
22. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31(3):545-548.
23. Washburn RA, McAuley E, Katula J, Mihalko SL, Boileau RA. The physical activity scale for the elderly (PASE): evidence for validity. J Clin Epidemiol. 1999;52(7):643-651. (Pubitemid 29281660)
24. Shah KR, Carr D, Roe CM, Miller JP, Coats M, Morris JC. Impaired physical performance and the assessment of dementia of the Alzheimer type. Alzheimer Dis Assoc Disord. 2004;18(3):112-119. (Pubitemid 39202185)
25. Nourhashémi F, Andrieu S, Gillette-Guyonnet S, et al. Is there a relationship between fat-free soft tissue mass and low cognitive function? results from a study of 7,105 women. J Am Geriatr Soc. 2002;50(11):1796-1801. (Pubitemid 35291722)
26. Kuo H-K, Jones RN, Milberg WP, et al. Cognitive function in normal-weight, overweight, and obese older adults: an analysis of the advanced cognitive training for independent and vital elderly cohort. J Am Geriatr Soc. 2006;54(1):97-103.
27. Deschamps V, Astier X, Ferry M, Rainfray M, Emeriau JP, Barberger-Gateau P. Nutritional status of healthy elderly persons living in Dordogne, France, and relation with mortality and cognitive or functional decline. Eur J Clin Nutr. 2002;56(4):305-312. (Pubitemid 34413823)
28. Silbert LC, Quinn JF, Moore MM, et al. Changes in premorbid brain volume predict Alzheimer's disease pathology. Neurology. 2003;61(4):487-492.
29. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404(6778):661-671. (Pubitemid 30205071)
30. Roubenoff R. Catabolism of aging: is it an inflammatory process? Curr Opin Clin Nutr Metab Care. 2003;6(3):295-299. (Pubitemid 40684606)
31. Kramer AF, Hahn S, Cohen NJ, et al. Ageing, fitness and neurocognitive function. Nature. 1999;400(6743):418-419.
32. Colcombe S, Kramer AF. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci. 2003;14(2):125-130. (Pubitemid 37283096)
33. Adlard PA, Perreau VM, Pop V, Cotman CW. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J Neurosci. 2005;25(17):4217-4221. (Pubitemid 40628765)
34. Doherty TJ. Invited review: aging and sarcopenia. J Appl Physiol. 2003;95(4):1717-1727.
35. Álvarez A, Cacabelos R, Sanpedro C, García-Fantini M, Aleixandre M. Serum TNFalpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease. Neurobiol Aging. 2007;28(4):533-536. (Pubitemid 46282207)
36. Gasparini L, Xu H. Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends Neurosci. 2003;26(8):404-406. (Pubitemid 37288973)
37. Cacabelos R, Alvarez XA, Franco-Maside A, Fernandez-Novoa L, Caamano J. Serum tumor necrosis factor (TNF) in Alzheimer's disease and multi-infarct dementia. Methods Find Exp Clin Pharmacol. 1994;16(1):29-35. (Pubitemid 24067673)
38. Chow LS, Albright RC, Bigelow ML, Toffolo G, Cobelli C, Nair KS. Mechanism of insulin's anabolic effect on muscle: measurements of muscle protein synthesis and breakdown using aminoacyl-tRNA and other surrogate measures [published online ahead of print May 16, 2006]. Am J Physiol Endocrinol Metab. 2006;291:E729-E736. (Pubitemid 44484914)
39. Tanaka M, Sawada M, Yoshida S, Hanaoka F, Marunouchi T. Insulin prevents apoptosis of external granular layer neurons in rat cerebellar slice cultures. Neurosci Lett. 1995;199(1):37-40.
40. Schubert M, Gautam D, Surjo D, et al. Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci U S A. 2004;101(9):3100-3105. (Pubitemid 38327741)
41. Beck KD, Powell-Braxton L, Widmer HR, Valverde J, Hefti F. Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron. 1995;14(4):717-730.